Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve

Objective We aimed to analyse the incidence of prosthesis–patient mismatch (PPM) and elevated gradients after aortic valve in valve (ViV), and to evaluate predictors and associations with clinical outcomes of this adverse event. - Methods A total of 910 aortic ViV patients were investigated. Elevate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bleiziffer, Sabine (VerfasserIn) , Bekeredjian, Raffi (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 January 2018
In: Heart
Year: 2018, Jahrgang: 104, Heft: 10, Pages: 828-834
ISSN:1468-201X
DOI:10.1136/heartjnl-2017-312422
Online-Zugang:Verlag, Volltext: https://doi.org/10.1136/heartjnl-2017-312422
Verlag: https://heart.bmj.com/content/104/10/828
Volltext
Verfasserangaben:Sabine Bleiziffer, Magdalena Erlebach, Matheus Simonato, Philippe Pibarot, John Webb, Lukas Capek, Stephan Windecker, Isaac George, Jan-Malte Sinning, Eric Horlick, Massimo Napodano, David M. Holzhey, Petur Petursson, Alfredo Cerillo, Nikolaos Bonaros, Enrico Ferrari, Mauricio G. Cohen, Giselle Baquero, Tara L. Jones, Ankur Kalra, Michael J. Reardon, Adnan Chhatriwalla, Vasco Gama Ribeiro, Sami Alnasser, Nicolas M. Van Mieghem, Christian Jörg Rustenbach, Joachim Schofer, Santiago Garcia, Tobias Zeus, Didier Champagnac, Raffi Bekeredjian, Ran Kornowski, Rüdiger Lange, Danny Dvir

MARC

LEADER 00000caa a2200000 c 4500
001 1678731501
003 DE-627
005 20230426135320.0
007 cr uuu---uuuuu
008 191011s2018 xx |||||o 00| ||eng c
024 7 |a 10.1136/heartjnl-2017-312422  |2 doi 
035 |a (DE-627)1678731501 
035 |a (DE-599)KXP1678731501 
035 |a (OCoLC)1341245255 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bleiziffer, Sabine  |d 1976-  |e VerfasserIn  |0 (DE-588)123830915  |0 (DE-627)629423148  |0 (DE-576)185088511  |4 aut 
245 1 0 |a Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve  |c Sabine Bleiziffer, Magdalena Erlebach, Matheus Simonato, Philippe Pibarot, John Webb, Lukas Capek, Stephan Windecker, Isaac George, Jan-Malte Sinning, Eric Horlick, Massimo Napodano, David M. Holzhey, Petur Petursson, Alfredo Cerillo, Nikolaos Bonaros, Enrico Ferrari, Mauricio G. Cohen, Giselle Baquero, Tara L. Jones, Ankur Kalra, Michael J. Reardon, Adnan Chhatriwalla, Vasco Gama Ribeiro, Sami Alnasser, Nicolas M. Van Mieghem, Christian Jörg Rustenbach, Joachim Schofer, Santiago Garcia, Tobias Zeus, Didier Champagnac, Raffi Bekeredjian, Ran Kornowski, Rüdiger Lange, Danny Dvir 
264 1 |c 19 January 2018 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.10.2019 
520 |a Objective We aimed to analyse the incidence of prosthesis–patient mismatch (PPM) and elevated gradients after aortic valve in valve (ViV), and to evaluate predictors and associations with clinical outcomes of this adverse event. - Methods A total of 910 aortic ViV patients were investigated. Elevated residual gradients were defined as ≥20 mm Hg. PPM was identified based on the indexed effective orifice area (EOA), measured by echocardiography, and patient body mass index (BMI). Moderate and severe PPM (cases) were defined by European Association of Cardiovascular Imaging (EACVI) criteria and compared with patients without PPM (controls). - Results Moderate or greater PPM was found in 61% of the patients, and severe in 24.6%. Elevated residual gradients were found in 27.9%. Independent risk factors for the occurrence of lower indexed EOA and therefore severe PPM were higher gradients of the failed bioprosthesis at baseline (unstandardised beta −0.023; 95% CI −0.032 to –0.014; P<0.001), a stented (vs a stentless) surgical bioprosthesis (unstandardised beta −0.11; 95% CI −0.161 to –0.071; P<0.001), higher BMI (unstandardised beta −0.01; 95% CI −0.013 to –0.007; P<0.001) and implantation of a SAPIEN/SAPIEN XT/SAPIEN 3 transcatheter device (unstandardised beta −0.064; 95% CI −0.095 to –0.032; P<0.001). Neither severe PPM nor elevated gradients had an association with VARC II-defined outcomes or 1-year survival (90.9% severe vs 91.5% moderate vs 89.3% none, P=0.44). - Conclusions Severe PPM and elevated gradients after aortic ViV are very common but were not associated with short-term survival and clinical outcomes. The long-term effect of poor post-ViV haemodynamics on clinical outcomes requires further evaluation. 
650 4 |a prosthetic heart valves 
650 4 |a transcatheter valve interventions 
650 4 |a valve disease surgery 
650 4 |a valvular heart disease 
700 1 |a Bekeredjian, Raffi  |d 1972-  |e VerfasserIn  |0 (DE-588)122088271  |0 (DE-627)705767930  |0 (DE-576)293085781  |4 aut 
773 0 8 |i Enthalten in  |t Heart  |d [London] : BMJ Publ. Group, 1996  |g 104(2018), 10, Seite 828-834  |h Online-Ressource  |w (DE-627)269538925  |w (DE-600)1475501-4  |w (DE-576)078940427  |x 1468-201X  |7 nnas  |a Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve 
773 1 8 |g volume:104  |g year:2018  |g number:10  |g pages:828-834  |g extent:7  |a Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve 
856 4 0 |u https://doi.org/10.1136/heartjnl-2017-312422  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://heart.bmj.com/content/104/10/828  |x Verlag 
951 |a AR 
992 |a 20191011 
993 |a Article 
994 |a 2018 
998 |g 122088271  |a Bekeredjian, Raffi  |m 122088271:Bekeredjian, Raffi  |d 910000  |d 910100  |e 910000PB122088271  |e 910100PB122088271  |k 0/910000/  |k 1/910000/910100/  |p 31 
999 |a KXP-PPN1678731501  |e 3521608840 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"recId":"1678731501","note":["Gesehen am 11.10.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve","title":"Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve"}],"person":[{"display":"Bleiziffer, Sabine","roleDisplay":"VerfasserIn","role":"aut","family":"Bleiziffer","given":"Sabine"},{"roleDisplay":"VerfasserIn","display":"Bekeredjian, Raffi","role":"aut","family":"Bekeredjian","given":"Raffi"}],"relHost":[{"disp":"Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valveHeart","note":["Gesehen am 12.12.12"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"269538925","pubHistory":["75.1996 -"],"part":{"volume":"104","text":"104(2018), 10, Seite 828-834","extent":"7","year":"2018","issue":"10","pages":"828-834"},"titleAlt":[{"title":"Heart and Education in Heart"},{"title":"Education in heart"},{"title":"Heart online"}],"title":[{"title":"Heart","title_sort":"Heart"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"[London]","dateIssuedDisp":"1996-","publisher":"BMJ Publ. Group","dateIssuedKey":"1996"}],"id":{"eki":["269538925"],"zdb":["1475501-4"],"issn":["1468-201X"]}}],"physDesc":[{"extent":"7 S."}],"id":{"eki":["1678731501"],"doi":["10.1136/heartjnl-2017-312422"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"19 January 2018"}],"name":{"displayForm":["Sabine Bleiziffer, Magdalena Erlebach, Matheus Simonato, Philippe Pibarot, John Webb, Lukas Capek, Stephan Windecker, Isaac George, Jan-Malte Sinning, Eric Horlick, Massimo Napodano, David M. Holzhey, Petur Petursson, Alfredo Cerillo, Nikolaos Bonaros, Enrico Ferrari, Mauricio G. Cohen, Giselle Baquero, Tara L. Jones, Ankur Kalra, Michael J. Reardon, Adnan Chhatriwalla, Vasco Gama Ribeiro, Sami Alnasser, Nicolas M. Van Mieghem, Christian Jörg Rustenbach, Joachim Schofer, Santiago Garcia, Tobias Zeus, Didier Champagnac, Raffi Bekeredjian, Ran Kornowski, Rüdiger Lange, Danny Dvir"]}} 
SRT |a BLEIZIFFERINCIDENCEP1920